Massachusetts General Hospital (MGH) researchers along with collaborators from Massachusetts Institute of Technology (MIT) and Alnylam Pharmaceuticals have found a way to block, in an animal model, the damaging inflammation that contributes to many disease conditions. In their report receiving early online publication in Nature Biotechnology, the investigators describe using small interfering RNA technology to silence the biochemical signals that attract a particular group of inflammatory cells to areas of tissue damage.
"The white blood cells known as monocytes play a critical role in the early stages of the immune response," says Matthias Nahrendorf, MD, PhD, of the MGH Center for Systems Biology, the paper's senior author. "We now know there are two subsets of monocytes an inflammatory subset that defends against pathogens and a reparative subset that supports healing. But if the inflammatory response is excessive, it can block the healing process and exacerbate conditions such heart disease and cancer."
Cells damaged by injury or disease release a cocktail of chemicals called cytokines that attract immune cells to the site of the damage. Inflammatory monocytes are guided to sites of tissue injury by a receptor protein called CCR2, and the MGH-led team devised a strategy targeting that molecule to block the inflammatory process but not the action of the reparative monocytes.
Small interfering RNA (siRNA) technology prevents production of specific proteins by binding to associated messenger RNA molecules and preventing their translation. Because the technique requires extreme precision in developing the right siRNA molecule and delivering it to the correct cellular location, the MGH team collaborated with Alnylam scientists who are experts in RNA-interference-based therapeutics and with MIT investigators Robert Langer, ScD, and Daniel Anderson, PhD, who have developed a nanoparticle-based system for delivering mole
'/>"/>
| Contact: Sue McGreevey smcgreevey@partners.org 617-724-2764 Massachusetts General Hospital Source:Eurekalert |
Related biology news :
1. La Jolla Institute discovers novel mechanism for preventing infection via bodys mucosal borders
2. Novel drug combination offers therapeutic promise for hard-to-treat cancers
3. Novel approach scores first success against elusive cancer gene
4. Novel method for increasing antibiotic yields
5. Tropical coral could be used to create novel sunscreens for human use, say scientists
6. A novel mechanism that regulates pro-inflammatory cells is identified
7. Novel analysis by Allen Institute sheds new light on the mechanisms of brain development
8. Novel gene increases yeasts appetite for plant sugars
9. Life scientists use novel technique to produce genetic map for African Americans
10. Parkinsons Disease Foundation announces $1 million for novel studies into Parkinsons
11. UTHealth awarded FEMA grant to explore novel obesity risk factor among firefighters
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |